Nadia Malik, MD

Assistant Professor, Department of Radiation Medicine

Roswell Park Cancer Institute

Background Information

Education and Training:

2005-2007 - Northeast Ohio Medical University (Neomed), Rootstown, OH Doctorate of Medicine (M.D.)

2003-2005 - St. George’s University School of Medicine, Grenada, West Indies, Basic Science G.P.A. 3.78

2003-2005 - National Dean's List

Peer Mentor - advising incoming students on personal and academic matters.

2002 - State University of New York at Buffalo, Buffalo, NY

Bachelor of Arts - English, Graduated Cum Laude

Professional Experience:

1/2011-5/2012 - Roswell Park Cancer Institute, Buffalo, NY, Chief Resident (PGY5)

7/2008-present - Roswell Park Cancer Institute, Buffalo, NY, Radiation Medicine Residency Program

7/2007-7/2008 - Loyola Medical Center, Maywood, IL Preliminary medicine intern

Professional Memberships:

2008-present - American Society for Therapeutic Radiology and Oncology

2008-present - Association of Residents in Radiation Oncology

2008-present - American Brachytherapy Society

The Association of Physicians of Pakistani descent of North America (APPNA)

1/2009-4/2011 - University at Buffalo Resident Committee

Publications

Publications:

Malik NK , Wilding GE , Gibbs JF , Kuvshinoff BW , Iyer RV , Flaherty L , Ma W , May KS , Chandrasekhar R , Yang GY. Chemoradiotherapy vs. chemotherapy alone in patients with locally advanced unresectable pancreatic carcinoma: a 10-year experience. International journal of radiation oncology, biology, physics 2010; 78(3 Suppl. 1):S311-S312
Yang G , Wilding G , Kuvshinoff B , Ma W , Flaherty L , Watroba N , May KS , Chandrasekhar R , Malik N , Gibbs J. Change in CA 19-9 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancer. International journal of radiation oncology, biology, physics 2010; 78(3 Suppl. 1):S298
Malik NK, Warren GW, Yang G, Zeeck K, Papsidero T, Patil S, Khushalani NI, Sher T, Yendamuri SS, Nava HR, Salerno May K. Response-based outcomes in patients with esophageal cancer treated with primarily non-cisplatin and 5-fluorouracil-based trimodality therapy : ASCO Meeting Abstracts Part 1. Journal of clinical oncology 2011; 29(15 Suppl.):e14620
Salerno May K, Malik NK, Yang G, Patil S, Flaherty L, Khushalani NI, Sher T, Yendamuri SS, Nava HR, Warren GW. The effect of smoking history on response and survival outcomes patients with in esophageal cancer treated with neoadjuvant concurrent chemoradiotherapy followed by surgery : ASCO Meeting Abstracts Part 1. Journal of clinical oncology 2011; 29(15 Suppl.):e14601
Malik NK, May KS, Groman A, Patil S, Gibbs J, Kuvshinoff B, Ma W, Iyer R, Warren G, Yang G. Outcomes and Tolerability of Treatment for Locally Advanced Pancreatic Cancer Patients 65 Years or Older. International journal of radiation oncology, biology, physics 2011; 81(2 Suppl.):S336
Malik NK, Patil S, Groman A, Nava H, Yendamuri S, Nurkin S, Sher T, Warren G, Yang G, May K. Outcomes in Patients 65 Years or Older Treated with Trimodality Therapy for Esophageal Carcinoma. International journal of radiation oncology, biology, physics 2011; 81(2 Suppl.):S312
Patil SS, May KS, Hackett RA, Hales LD, VanBenthuysen LT, Malik NK, Schmitt JD, Yang GY, Warren GW. A Comparison of VMAT, IMRT, and 3DCRT in the Treatment Planning of Patients with Distal Esophageal Cancer. International journal of radiation oncology, biology, physics 2011; 81(2 Suppl.):S324-S325